微波消融联合肝动脉插管化疗栓塞术与手术切除巴塞罗那B期原发性肝癌的临床疗效分析

Abstract
Figure/Table
References (16)
Related Citation (3)

Download: PDF (0 KB) HTML (32 KB)
Export: BibTeX | EndNote (RIS)

Abstract ObjectiveTo compare survival and prognosis of microwave ablation combined with transcatheter arterial chemoembolization (TACE)and surgical resection for patients with primary hepatocellular carcinoma of BCLC-B.MethodsClinacal date of 40 patienswho were diagnosed as primary hepatocellular carcinoma of BCLC-B in the First Affiliated Hospital of Henan University of Traditional Chinese Medicine from January 2010 to June 2013 were retrospectively analyzed and divided intominimally invasive group and operation group according to the different treatment methods,each group of 20 cases,patients in theminimally invasive group was treated with microwave ablation combined with TACE,while patients in the operation group was treated by surgical resection,near and long-term treatment effect in two groups were compared.ResultsThe 3-year survial rates were 85%in theminimally invasive group,and 55%in the operation group,and the difference was statistically significant(P=0.04).ConclusionThe efficacy ofmicrowave ablation combined with TACE in the treatment of primary hepatocellular carcinoma of BCLC-B is affirmat,and it could be considered as the first-line treatmentmethod for patientswith primary hepatocellular carcinoma of BCLC-B.

Key words： Primary hepatocellular carcinoma Microwave ablation Transcatheter aterial chemoembolization Surgical resection

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WANG Xin-ting
	ZHANG Chuan-lei
	CHEN Xiao-qi
	CHEN Xin-ju

Cite this article:

WANG Xin-ting,ZHANG Chuan-lei,CHEN Xiao-qi, et al. Clinical efficacy analysis of m icrowave ablation combined with transcatheter arterial chemoembolization and surgical resection for patients with primary hepatocellular carcinoma of BCLC-B[J]. 中国当代医药, 2016, 23(34): 69-71.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2016/V23/I34/69

[1]	Chen WQ，Zheng RS，Zhang SW.Liver cancer incidence and mortality in China,2009[J].Chin J Cancer，2013，32（4）：162-169.
[2]	陈敏华.关于肝癌消融治疗学科建设的若干思考[J].中国介入影像与治疗学，2015，12（1）：3-5.
[3]	戴朝六，贾昌俊.肝细胞癌规范诊治流程评价[J].中国实用外科杂志，2014，34（8）：690-695.
[4]	邓兴，胡鸿，游箭，等.TACE联合微波消融治疗原发性肝癌的效果分析[J].西部医学，2016，28（24）：524-527.
[5]	高飞，庞志刚，韩斌，等.肝动脉化疗栓塞联合射频消融术治疗大肝癌的疗效及生存分析[J].介入放射学杂志，2016，25（4）：316-319.
[6]	杨藩，张二雷，肖震宇，等.经皮微波消融与手术切除治疗合并肝硬化的单发小肝癌的疗效比较（附250例）[J].华中科技大学学报（医学版），2016，45（2）：185-188.
[7]	王小方，黄文峰，聂剑.手术切除与微波消融对小肝癌治疗效果的比较[J].实用中西医结合临床，2014，14（11）：33-34.
[8]	许贇，王能，沈强，等.经皮微波消融治疗较大原发性肝癌的可行性及疗效研究[J].中国普通外科杂志，2016，25（1）：39-44.
[9]	张洪新.肝细胞肝癌微创综合治疗的现状与展望[J].中华肝脏外科手术学电子杂志，2013，2（3）：146-147.
[10]	王悦华.原发性肝癌多学科整体治疗方案的设计与实施[J].临床肝胆病杂志，2014，30（3）：214-217.
[11]	陈耀庭，许林锋.血管介入治疗在肝癌综合治疗中应用与评价[J].中国实用外科杂志，2014，34（8）：702-705.
[12]	Forner A，Gilabert M，Bruix J，et al.Treatment of intermediate-stagehepatocellular carcinoma[J].NatRev Clin Oncol，2014，11（9）：525-535.
[13]	张建刚，叶知锋，郭俊华，等.手术前后经肝动脉化疗治疗原发性肝癌的临床观察[J].中国现代医生，2016，54（1）：88-91.
[14]	叶胜龙.关注原发性肝癌多学科治疗[J].中国医学前沿杂志，2014，6（5）：1-3.
[15]	杨振宇，杜锡林，杨涛，等.多结节肝细胞癌的基础研究及治疗策略[J].临床肝胆病杂志，2016，32（6）：1212-1215.
[16]	戴朝六，赵阳.原发性肝癌的综合治疗[J].中国普外基础与临床杂志，2014，21（2）：133-137.